Fractional allelic loss in non-end-stage cirrhosis

Correlations with hepatocellular carcinoma development during follow-up

Massimo Roncalli, Paolo Bianchi, Giorgia Ceva Grimaldi, Daniele Ricci, Luigi Laghi, Marco Maggioni, Enrico Opocher, Mauro Borzio, Guido Coggi

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is usually preceded by cirrhosis whose genetic background is still poorly understood. The aim of this study was to evaluate, in non-end-stage cirrhosis, the fractional allelic loss (FAL) at loci mostly reported to be altered in HCC and the microsatellite instability (MSI). Twenty cases of cirrhosis were retrospectively selected. Eleven had developed an HCC during the follow-up (HCC-prone group), while 9 remained HCC-free (HCC-free group). Microdissected hepatocellular cirrhotic nodules from basal liver biopsies, were studied at 20 loci (on the chromosomal arms 1p and 1q, 3p, 4q, 6q, 7q, 8p, 13q, and 18q) and with the mononucleotide repeats BAT26 and TGFbIIR. Genetic changes were detected in both groups. Overall, the FAL index was statistically increased in the HCC-prone group (0.213) as compared to the HCC-free group (0.094; P = .044). Allelic loss at chromosomal arms 1p, 4q, 13q, 18q, and concurrent losses at more than 3 loci were confined to the HCC-prone group. In both groups, MSI was never ascertained using BAT26 and TGFbIIR. In conclusion, an increased FAL index and the lack of MSI characterize the non-end-stage cirrhosis of patients undergoing HCC during follow-up. These data emphasize the role of early clonal changes in chronic liver disease, and their potential predictive significance for clinical use.

Original languageEnglish
Pages (from-to)846-850
Number of pages5
JournalHepatology
Volume31
Issue number4
Publication statusPublished - 2000

Fingerprint

Loss of Heterozygosity
Hepatocellular Carcinoma
Fibrosis
Microsatellite Instability
Liver Diseases
Chronic Disease
Biopsy

ASJC Scopus subject areas

  • Hepatology

Cite this

Fractional allelic loss in non-end-stage cirrhosis : Correlations with hepatocellular carcinoma development during follow-up. / Roncalli, Massimo; Bianchi, Paolo; Grimaldi, Giorgia Ceva; Ricci, Daniele; Laghi, Luigi; Maggioni, Marco; Opocher, Enrico; Borzio, Mauro; Coggi, Guido.

In: Hepatology, Vol. 31, No. 4, 2000, p. 846-850.

Research output: Contribution to journalArticle

@article{ced08a858da7474eba241583d262eb0d,
title = "Fractional allelic loss in non-end-stage cirrhosis: Correlations with hepatocellular carcinoma development during follow-up",
abstract = "Hepatocellular carcinoma (HCC) is usually preceded by cirrhosis whose genetic background is still poorly understood. The aim of this study was to evaluate, in non-end-stage cirrhosis, the fractional allelic loss (FAL) at loci mostly reported to be altered in HCC and the microsatellite instability (MSI). Twenty cases of cirrhosis were retrospectively selected. Eleven had developed an HCC during the follow-up (HCC-prone group), while 9 remained HCC-free (HCC-free group). Microdissected hepatocellular cirrhotic nodules from basal liver biopsies, were studied at 20 loci (on the chromosomal arms 1p and 1q, 3p, 4q, 6q, 7q, 8p, 13q, and 18q) and with the mononucleotide repeats BAT26 and TGFbIIR. Genetic changes were detected in both groups. Overall, the FAL index was statistically increased in the HCC-prone group (0.213) as compared to the HCC-free group (0.094; P = .044). Allelic loss at chromosomal arms 1p, 4q, 13q, 18q, and concurrent losses at more than 3 loci were confined to the HCC-prone group. In both groups, MSI was never ascertained using BAT26 and TGFbIIR. In conclusion, an increased FAL index and the lack of MSI characterize the non-end-stage cirrhosis of patients undergoing HCC during follow-up. These data emphasize the role of early clonal changes in chronic liver disease, and their potential predictive significance for clinical use.",
author = "Massimo Roncalli and Paolo Bianchi and Grimaldi, {Giorgia Ceva} and Daniele Ricci and Luigi Laghi and Marco Maggioni and Enrico Opocher and Mauro Borzio and Guido Coggi",
year = "2000",
language = "English",
volume = "31",
pages = "846--850",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Fractional allelic loss in non-end-stage cirrhosis

T2 - Correlations with hepatocellular carcinoma development during follow-up

AU - Roncalli, Massimo

AU - Bianchi, Paolo

AU - Grimaldi, Giorgia Ceva

AU - Ricci, Daniele

AU - Laghi, Luigi

AU - Maggioni, Marco

AU - Opocher, Enrico

AU - Borzio, Mauro

AU - Coggi, Guido

PY - 2000

Y1 - 2000

N2 - Hepatocellular carcinoma (HCC) is usually preceded by cirrhosis whose genetic background is still poorly understood. The aim of this study was to evaluate, in non-end-stage cirrhosis, the fractional allelic loss (FAL) at loci mostly reported to be altered in HCC and the microsatellite instability (MSI). Twenty cases of cirrhosis were retrospectively selected. Eleven had developed an HCC during the follow-up (HCC-prone group), while 9 remained HCC-free (HCC-free group). Microdissected hepatocellular cirrhotic nodules from basal liver biopsies, were studied at 20 loci (on the chromosomal arms 1p and 1q, 3p, 4q, 6q, 7q, 8p, 13q, and 18q) and with the mononucleotide repeats BAT26 and TGFbIIR. Genetic changes were detected in both groups. Overall, the FAL index was statistically increased in the HCC-prone group (0.213) as compared to the HCC-free group (0.094; P = .044). Allelic loss at chromosomal arms 1p, 4q, 13q, 18q, and concurrent losses at more than 3 loci were confined to the HCC-prone group. In both groups, MSI was never ascertained using BAT26 and TGFbIIR. In conclusion, an increased FAL index and the lack of MSI characterize the non-end-stage cirrhosis of patients undergoing HCC during follow-up. These data emphasize the role of early clonal changes in chronic liver disease, and their potential predictive significance for clinical use.

AB - Hepatocellular carcinoma (HCC) is usually preceded by cirrhosis whose genetic background is still poorly understood. The aim of this study was to evaluate, in non-end-stage cirrhosis, the fractional allelic loss (FAL) at loci mostly reported to be altered in HCC and the microsatellite instability (MSI). Twenty cases of cirrhosis were retrospectively selected. Eleven had developed an HCC during the follow-up (HCC-prone group), while 9 remained HCC-free (HCC-free group). Microdissected hepatocellular cirrhotic nodules from basal liver biopsies, were studied at 20 loci (on the chromosomal arms 1p and 1q, 3p, 4q, 6q, 7q, 8p, 13q, and 18q) and with the mononucleotide repeats BAT26 and TGFbIIR. Genetic changes were detected in both groups. Overall, the FAL index was statistically increased in the HCC-prone group (0.213) as compared to the HCC-free group (0.094; P = .044). Allelic loss at chromosomal arms 1p, 4q, 13q, 18q, and concurrent losses at more than 3 loci were confined to the HCC-prone group. In both groups, MSI was never ascertained using BAT26 and TGFbIIR. In conclusion, an increased FAL index and the lack of MSI characterize the non-end-stage cirrhosis of patients undergoing HCC during follow-up. These data emphasize the role of early clonal changes in chronic liver disease, and their potential predictive significance for clinical use.

UR - http://www.scopus.com/inward/record.url?scp=0034025348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034025348&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 846

EP - 850

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4

ER -